Press Release

EMC Delivers Documentum Solution Suite for Life Sciences

Solutions Simplify Compliance, Cost Reduction, Quality and Ease of Use; Available on the EMC OnDemand Hybrid Cloud Deployment Model

Story Highlights

  • EMC renews commitment to key industry with series of pre-configured solutions for Life Sciences companies; first available solution addresses Quality and Manufacturing
  • Solutions deliver a unified, configurable document control platform for compliance with FDA 21 CFR Part 11 regulations
  • Available as part of EMC® OnDemand, a hybrid cloud deployment model for enterprise applications
EMC WORLD, LAS VEGAS, May 22, 2012 - 

At EMC World 2012, EMC (NYSE:EMC) today announced the immediate availability of the EMC® Documentum® for Life Sciences Solution Suite. The suite is comprised of solutions built on top of the Documentum® platform and are optimized for the cloud with the EMC® OnDemand hybrid cloud deployment model. The solutions focus on simplifying compliance, cost reduction, cost avoidance and enabling process quality. The first available solution is Documentum® Quality and Manufacturing for Life Sciences.

Life Sciences companies look for the safest, fastest and most cost effective methods to bring quality drugs and medical devices to market. They look to ensure consistent revenue streams, speed production and delivery of products, and minimize disruption to ensure Good Manufacturing Processes (GMP). EMC's Documentum-based Life Sciences solutions deliver a unified, configurable document control platform for compliance with industry regulations. The foundation of these solutions include the Documentum® Enterprise Content Management platform, Documentum® D2 for configuration and intuitive user interfaces, implementation and migration services. The D2 configuration technology enables auditing, reporting and e-signature support for compliance, lifecycle management and document control services, and industry-specific modeling capabilities all designed for Life Sciences.

For more than 20 years, the Life Sciences industry and governments have relied on the Documentum brand for new drug and product submissions and on-going compliance. In delivering these solutions, EMC renews its commitment to a treasured industry.

Customer Benefits:

  • Simplified compliance: automated policy enforcement that enables compliance with FDA 21 CFR Part 11 compliance
  • Process quality and innovation: unify quality and control across document lifecycles and ensures process consistency
  • Ease of use: simplify document handling, streamline collaborative authoring, and enable compliant use of SharePoint® and Microsoft® Word
  • EMC OnDemand, a managed service by EMC experts, increases agility, saves time and costs, improves IT efficiency, and simplifies management of highly-complex applications.

EMC OnDemand is a hybrid cloud deployment model for enterprise-class applications, designed to help customers accelerate their journey to the cloud. Developed using a range of best-in-class technologies from VMware, RSA and EMC, the infrastructure can contain one or many EMC and EMC partner products and can be completely portable from one data center to another. It also enables customers to provision and configure the system for rapid deployment. In addition to the Life Sciences solutions, EMC OnDemand is available for EMC® Documentum® D2 for configuring intuitive user client interfaces to the EMC® Documentum® platform, EMC® Captiva® for enterprise capture, EMC® Document Sciences® for customer communications management and EMC® Documentum® for enterprise content management.

Executive Quote:

John O'Melia, Vice President of Worldwide Services for the Information Intelligence Group, EMC

"EMC is thrilled to deliver solutions for Life Sciences, marking a return to a key industry in a big way with comprehensive offerings that deliver highly configurable compliance products. Our focus on Good Manufacturing Processes enables companies to avoid costly disruptions and fines that easily reach seven figures."

The Information Intelligence Group division of EMC is focused on four key strategic priorities for customer success - delighting the "New User" of the Post PC era with a compelling, fast and modern user experience across a variety of end-point devices; accelerating our customers' journey to the cloud; delivering pervasive governance to protect information wherever it exists, and helping our customers transform their business with high value solutions. The Documentum Life Sciences Solution Suite is designed to help our customers transform their business.

Additional Resources:

About EMC

EMC Corporation is a global leader in enabling businesses and service providers to transform their operations and deliver IT as a service. Fundamental to this transformation is cloud computing. Through innovative products and services, EMC accelerates the journey to cloud computing, helping IT departments to store, manage, protect and analyze their most valuable asset — information — in a more agile, trusted and cost-efficient way. Additional information about EMC can be found at

Press Contacts

David De Jear
(925) 600-6790

EMC Documentum Captiva and Document Sciences are registered trademarks or trademarks of EMC Corporation in the United States and other countries. All other trademarks herein are the property of their respective holders.

This release contains "forward-looking statements" as defined under the Federal Securities Laws. Actual results could differ materially from those projected in the forward-looking statements as a result of certain risk factors, including but not limited to: (i) adverse changes in general economic or market conditions; (ii) delays or reductions in information technology spending; (iii) the relative and varying rates of product price and component cost declines and the volume and mixture of product and services revenues; (iv) competitive factors, including but not limited to pricing pressures and new product introductions; (v) component and product quality and availability; (vi) fluctuations in VMware, Inc.'s operating results and risks associated with trading of VMware stock; (vii) the transition to new products, the uncertainty of customer acceptance of new product offerings and rapid technological and market change; (viii) risks associated with managing the growth of our business, including risks associated with acquisitions and investments and the challenges and costs of integration, restructuring and achieving anticipated synergies; (ix) the ability to attract and retain highly qualified employees; (x) insufficient, excess or obsolete inventory; (xi) fluctuating currency exchange rates; (xii) threats and other disruptions to our secure data centers or networks; (xiii) our ability to protect our proprietary technology; (xiv) war or acts of terrorism; and (xv) other one-time events and other important factors disclosed previously and from time to time in EMC's filings with the U.S. Securities and Exchange Commission. EMC disclaims any obligation to update any such forward-looking statements after the date of this release.